| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/28/2004 | EP1412381A2 Meningococcus adhesins nada, app and orf40 |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412372A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
| 04/28/2004 | EP1307213B1 Chlorella preparations exhibiting immunomodulating properties |
| 04/28/2004 | EP1144656B1 Method for the isolation of ccc plasmid dna |
| 04/28/2004 | EP1062318B1 A prokaryotic cell comprising two copies of a gene transcribed in different directions |
| 04/28/2004 | EP0978558B1 Method for treating ethanol contained in exhaust gas |
| 04/28/2004 | EP0944723B1 Mammalian chemokines |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0910642B1 A method for increasing hemoprotein production in filamentous fungi |
| 04/28/2004 | EP0799317B1 Method for secreting thrombopoietin polypeptides |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0694063B1 An alpha-amylase from pyrococcus |
| 04/28/2004 | EP0367765B2 Astaxanthin-producing yeast cells, methods for their preparation and their use |
| 04/28/2004 | CN1492933A Method for production of D-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs |
| 04/28/2004 | CN1492931A Process for producing prenyl alcohol |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492764A Medicines for relieving intestinal disorders |
| 04/28/2004 | CN1492104A Method for reducing produced bacterial mud and mixture |
| 04/28/2004 | CN1492049A Process for producing L-leucine |
| 04/28/2004 | CN1492044A Method for raising activity of streptoverticillium to produce trans glutaminase |
| 04/28/2004 | CN1492039A Process for producing chitosan enzyme producing fungus and chitosan oligomer |
| 04/28/2004 | CN1492038A Method for producing target material by fermentation |
| 04/28/2004 | CN1492037A Process for preparing water bloom blue-green algae harvest on lake |
| 04/28/2004 | CN1491905A Long-acting microbial water purifying agent and its producing method |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/27/2004 | US6727409 Active against lepidoptera |
| 04/27/2004 | US6727373 High triglyceride content and high oxidative stability. |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727222 Transcriptional regulator |
| 04/27/2004 | US6727092 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
| 04/27/2004 | US6727087 Bioremediation of chromated pentachlorophenol; obtain wood, incubate with fungal inoculum, substrate and nutrient broth, aerate, monitor mixture for remediation of pentachlorophenol |
| 04/27/2004 | US6727084 Cold-active beta-galactosidase, the process for its preparation and the use thereof |
| 04/27/2004 | US6727083 Protein for use in the generation of bronchodilating agent, pesticides, fungicide, herbicides and for use in the treatment of diabetes |
| 04/27/2004 | US6727081 Microorganism isolated from chinese elm (Ulmus sp.) and process for preparing exopolysaccharides by employing the microorganism |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/27/2004 | CA1341455C Process for transforming gramineae and the products thereof |
| 04/22/2004 | WO2004033700A1 Method of coagulating poly-3-hydroxyalkanoic acid |
| 04/22/2004 | WO2004033693A1 Methods vectors plasmids and methods for increasing expression of recombinant polypeptides |
| 04/22/2004 | WO2004033691A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 04/22/2004 | WO2004033689A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 04/22/2004 | WO2004033688A1 Cap-binding protein |
| 04/22/2004 | WO2004033686A1 Novel protein and dna thereof |
| 04/22/2004 | WO2004033684A1 A method of altering levels of plasmids |
| 04/22/2004 | WO2004033671A1 The microorganism of which the fadr gene was knocked out on the chromosome and a process for producing l-threonine by fermentation with the same mutant |
| 04/22/2004 | WO2004033670A1 Culture method of controlling the composition of copolymer polyester |
| 04/22/2004 | WO2004033664A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/22/2004 | WO2004033646A2 Process for the biological production of 1,3-propanediol with high yield |
| 04/22/2004 | WO2004033624A2 Bio-based method for making mannitol |
| 04/22/2004 | WO2004033623A2 Animal component free meningococcal polysaccharide fermentation and seedbank development |
| 04/22/2004 | WO2004033471A2 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | WO2004033421A2 Improved production of bacterial strains |
| 04/22/2004 | WO2004032878A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032830A2 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 04/22/2004 | WO2004020639A3 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/22/2004 | WO2004015099A3 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 04/22/2004 | WO2004006643A3 Environmentally safe agricultural supplement |
| 04/22/2004 | WO2003095635A3 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003072014B1 Minicell compositions and methods |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 04/22/2004 | WO2003060066A8 Nucleic acid delivery and expression |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003016460A8 Method of fermentation |
| 04/22/2004 | WO2003014311A3 Methods for altering polyketide synthase genes |
| 04/22/2004 | WO2003004659A8 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002081658A8 Transgenic mice containing cacnb4 calcium ion channel gene disruptions |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | US20040078842 Protein with endo-chitinase activity |
| 04/22/2004 | US20040078838 Transgenic plant cells with reduced citrate synthase activity in comparison to wild type cells |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077090 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/22/2004 | US20040077086 Animal protein free media for cultivation of cells |
| 04/22/2004 | US20040077081 G250 antibodies are capable of eliciting a delayed immune response in cancer therapy, in the treatment of renal cell carcinoma and for the treatment of metastases after tumor surgery |
| 04/22/2004 | US20040077075 Microfermentors for rapid screening and analysis of biochemical processes |
| 04/22/2004 | US20040077069 Method for the production of a heterologous protein by a fungus |
| 04/22/2004 | US20040077063 Comprises contacting a terpene analog having a terminal methyl group, for example limonene, with a microbial cell which is capable of expressing a monooxygenase capable of terminal hydroxylation of an n-alkane |
| 04/22/2004 | US20040077058 Domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed |